Humoral immunogenicity and tolerability of heterologous ChAd/BNT compared with homologous BNT/BNT and ChAd/ChAd SARS-CoV-2 vaccination in hemodialysis patients: A multicenter prospective observational study

BACKGROUND: After the reports of severe adverse reactions to the AstraZeneca ChAdOx1-S-nCoV-19 vaccine, patients who had received one dose of ChAdOx1-S-nCoV-19 vaccine were recommended a second dose of Pfizer’s BNT162b2 vaccine. In hemodialysis patients, we compared the humoral immunogenicity and to...

Descripción completa

Detalles Bibliográficos
Autores principales: Haase, Michael, Lesny, Paul, Anderson, Mark, Cloherty, Gavin, Stec, Michael, Haase-Fielitz, Anja, Haarhaus, Mathias, Santos-Araújo, Carla, Veiga, Pedro Mota, Macario, Fernando
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8792133/
https://www.ncbi.nlm.nih.gov/pubmed/35084719
http://dx.doi.org/10.1007/s40620-022-01247-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8792133/
https://www.ncbi.nlm.nih.gov/pubmed/35084719
http://dx.doi.org/10.1007/s40620-022-01247-7

Ejemplares similares